These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2344682)

  • 1. Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina.
    Yokota M; Miyahara T; Iwase M; Watanabe M; Matsunami T; Kamihara S; Koide M; Saito H; Takeuchi J
    Circulation; 1990 Jun; 81(6):1887-98. PubMed ID: 2344682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.
    Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I
    J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Lam J; Chaitman BR; Crean P; Blum R; Waters DD
    J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
    Ram J; Freedman SB; Ogasawara S; Thomson A; Kelly DT
    Am J Cardiol; 1989 Apr; 63(12):802-6. PubMed ID: 2929436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M; Matsunami T; Kodama Y; Sobue T; Nishinaka Y; Iwase M; Miyahara T; Koide M; Saito H; Shibata S
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake.
    Kodama Y; Yokota M; Miyahara T; Matsunami T; Sobue T; Saito H
    Am Heart J; 1993 Sep; 126(3 Pt 1):587-93. PubMed ID: 8362713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
    Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I
    Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
    Detry JM; De Coster PM; Renkin J
    Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
    Takase B
    Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol].
    Petretta M; Morgano G; Arrichiello P; Breglio R; Lanzillo T; Mazza F; Bonaduce D
    G Ital Cardiol; 1990 Jun; 20(6):518-25. PubMed ID: 2227221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
    Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of nisoldipine on dipyridamole-induced myocardial ischemia: correlation with exercise electrocardiography.
    Lattanzi F; Paperini L; Orsini E; Paci AM; Levantesi D; Topi A; Reisenhofer B; Lucarini AR; Squarcini G
    Coron Artery Dis; 1998; 9(4):207-15. PubMed ID: 9649927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
    Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
    J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
    Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
    Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcium antagonists on exercise tests.
    Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
    Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
    Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.